Forty one patients with bleeding vascular ectasias of the upper gastrointestinal tract who required blood transfusion were treated with endoscopic Nd:YAG laser photocoagulation and followed for 34 months (median). Four distinct groups of patients were identified.
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Abstract Forty one patients with bleeding vascular ectasias of the upper gastrointestinal tract who required blood transfusion were treated with endoscopic Nd:YAG laser photocoagulation and followed for 34 months (median). Four distinct groups of patients were identified. There was a sustained reduction in transfusion requirements after laser treatment in all those with single (nine patients) and multiple (seven patients) angiodysplasia, in 12 of 16 (75%) patients with watermelon stomachs, and in six of nine (66%) patients with hereditary haemorrhagic telangiectasia. Overall, 25 patients (61%) required minimal or no transfusion after treatment and nine (22%) whose bleeding was controlled initially, later developed recurrent bleeding which was controlled with further laser (total 34 of 41, 83%). Surgery succeeded in a further three patients (7%) in whom laser had failed (in one case possibly because of laser induced haemorrhage). Five more cases of possible laser induced haemorrhage resolved with conservative treatment. One patient sustained a treatment related perforation and died: one patient with cirrhosis died of encephalopathy within one month of starting laser treatment. In two patients transfusion requirements were unchanged despite laser. Nd:YAG laser is a safe and effective treatment for most patients with upper gastrointestinal angiodysplasia. (Gut 1993; 34: 470-475) Vascular ectasias of the upper gastrointestinal tract are a relatively rare cause of recurrent and sometimes severe blood loss. They are increasingly being diagnosed in patients with lesions that may have been regarded as unimportant in the past. This is, at least partly a result of the proliferation of new 
EXCLUSIONS
The following groups of patients were excluded: (i) Patients in whom no transfusions were required (two patients) (as transfusion requirements were used to assess results).
(ii) Patients who refused further treatment before adequate coagulation was achieved (two patients).
(iii) Follow up ofless than six months available (two patients).
(iv) Patients with other pathology (one patient). This patient had been extensively investigated at another hospital and found to have several small stomach angiodysplasias. Despite a good laser result further transfusions were required. Repeat colonoscopy showed a small caecal cancer which was graded Dukes's A on histology. It was resected and the patient remains well, with no blood loss, a year later.
TECHNIQUES
The endoscopic and laser techniques have been published in detail elsewhere."4"5' It is particularly important that care is taken with suction to avoid endoscope trauma that can be mistaken for vascular lesions. Gastric secretions and blood are cleared away by gentle washing. The power setting is adjusted as necessary to ensure that the mucosal surface is blanched when treated in 0 5s pulses (usually 50 W). The aim is to coagulate tissue down to the submucosa, where most ofthe abnormal vessels are situated; the mucosal lesion represent only the tip of the iceberg.'4 Lesions that bled spontaneously and those which oozed on gentle washing were considered most likely to be important sites of blood loss and were treated first. Treatment was started at the lesion edge in order to coagulate abnormal feeding vessels in adjacent submucosa.
Most patients with hereditary haemorrhagic telangiectasia and multiple angiodysplasias and all those with watermelon stomachs required repeated sessions to coagulate all visible lesions in contrast to those with single angiodysplasias where one or two sessions was usually adequate. All patients were given at least a four week course of H2 receptor antagonists after laser in order to assist induced ulcer healing.
FOLLOW UP
After diagnosis a pragmatic approach was taken toward further investigation. Colonscopy was initially deemed unnecessary in patients who presented with haematemesis and in those with lesions seen to be bleeding actively or which showed stigmata of recent bleeding. All patients who continued to have clinically important bleeding underwent further investigation. Overall, 13 patients underwent colonscopy: small lesions were detected in four but these were thought to be clinically unimportant. All patients were given iron supplements and blood transfusions as required to maintain an adequate haemoglobin concentration. At initial referral, the blood transfusion requirements were documented from the date of the first transfusion and subsequently on a prospective basis. These data were used to assess the efficacy of treatment. Long term follow up was carried out six monthly at the referring hospitals and by our research sister (DM or MT). All patients were seen again at this hospital when further bleeding occurred. One treatment was given at each admission, and a period of four to six weeks between treatments allowed induced ulcers to heal. The duration of follow up for each group is given in Table III . Patients with single angiodysplasias required a median of two procedures, which were carried out in the first year of treatment (mostly in the first three month period). Those with multiple angiodysplasias required a median of three procedures in the first two years of treatment. In contrast, patients with hereditary haemorrhagic telangiectasia and watermelon stomachs required a median of six treatments over two years, and they continued to require further regular treatments after this period. Patients who presented with further bleeding had lesions in the same distribution as that noted at previous endoscopies.
All but one patient were followed up to the second half of 1990. Eleven patients died during follow up. Two died shortly after the initial treatment (see results), three died from cardiac Figure 2 . These data are presented as 24 30 above. As the follow up periods increase, the difference between requirements before and after narrow, and statistical difference is lost after two years (Wilcoxon signed rank). These results look better than ours but this may be explained by patient selection and short follow up; almost all our patients came as tertiary referrals, often with a long history of anaemia and a total transfusion requirement greater than that in other published series. The median total blood loss before treatment in our patients was 11 units and the median duration of symptoms was three years. Our follow up is longer (33 months median) and in our experience the incidence of rebleeding increases with time. It could be argued that patients with this lesion would be better treated with antrectomy, which is curative. This group, however, are elderly and have a high incidence of concurrent medical conditions which substantially increases the risk of surgery. Indeed the two treatment failures who died in this group had advanced liver disease and were not deemed fit for surgery in any circumstances. We feel that endoscopic treatment should be attempted first in these patients but would not rule out surgery for difficult cases.
Delayed haemorrhage is now a well established complication of laser treatment. It was first documented in 198222 and has been seen by us and other groups.'4"" Six patients bled after laser and one of them required surgery, although all of these were bleeding heavily before treatment. It is therefore difficult to determine if the laser was really responsible and 
